Protective effect of low-dose aspirin against acute cellular allograft rejection after primary liver transplantation
- PMID: 36746180
- DOI: 10.1097/LVT.0000000000000093
Protective effect of low-dose aspirin against acute cellular allograft rejection after primary liver transplantation
Comment in
-
Reply.Liver Transpl. 2023 Apr 1;29(4):E5. doi: 10.1097/LVT.0000000000000094. Epub 2023 Feb 28. Liver Transpl. 2023. PMID: 36847127 No abstract available.
Comment on
-
Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation.Liver Transpl. 2022 Dec;28(12):1888-1898. doi: 10.1002/lt.26534. Epub 2022 Aug 5. Liver Transpl. 2022. PMID: 35735232 Free PMC article.
References
-
- Oberkofler CE, Raptis DA, Muller PC, Sousa da Silva RX, Lehmann K, Ito T, et al. Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation. Liver Transpl. 2022;28:1888–98.
-
- Wei Q, Wang K, Yang M, Chen J, Shen T, Song P, et al. Recipient gender and body mass index are associated with early acute rejection in donation after cardiac death liver transplantation. Clin Res Hepatol Gastroenterol. 2020;44s:100004.
-
- Bommena S, Fallon MB, Rangan P, Hirsch K, Mehta S. Risk factors and management of hepatic artery stenosis post liver transplantation. Dig Liver Dis. 2022;54:1052–9.
-
- Becchetti C, Dirchwolf M, Schropp J, Magini G, Müllhaupt B, Immer F, et al. Use of statins after liver transplantation is associated with improved survival: results of a nationwide study. Aliment Pharmacol Ther. 2022; 56:1194–204.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
